#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	2202	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2539	168.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1657	1657	C	260	C	168	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	2202	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2539	168.6	0	HET	.	.	.	C925T	.	925	925	C	1398	1398	C	216	C,T	66,72	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4120	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3680	212.0	0	.	n	.	0	T695C	SNP	695	695	T	1119	1119	C	302	C	194	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4120	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3680	212.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1761	1761	A	241	A,G	162,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4120	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3680	212.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2395	2395	C	199	C	127	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4120	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3680	212.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2469	2469	A	196	A	126	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4120	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3680	212.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3021	3021	C	250	C	161	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	27	140	folP	852	852	100.0	folP.l15.c4.ctg.1	1348	19.0	1	SNP	p	R228S	1	.	.	682	684	AGC	803	805	AGC	24;24;24	A;G,A;C,A	16;16,1;16,1	folP.WHO_K_01359c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_Z_01155	gyrA.WHO_Z_01155	1	1	0	408	gyrA	2751	2310	99.96	gyrA.l6.c17.ctg.1	2456	26.3	1	SNP	p	S91F	1	.	.	271	273	TTC	350	352	TTC	34;34;34	T;T;C	23;22;23	gyrA.WHO_Z_01155:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_Z_01155	gyrA.WHO_Z_01155	1	1	0	408	gyrA	2751	2310	99.96	gyrA.l6.c17.ctg.1	2456	26.3	1	SNP	p	D95N	1	.	.	283	285	AAC	362	364	AAC	38;38;38	A;A;C	24;24;24	gyrA.WHO_Z_01155:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_Z_01155	gyrA.WHO_Z_01155	1	1	0	408	gyrA	2751	2310	99.96	gyrA.l6.c17.ctg.1	2456	26.3	1	SNP	p	N95G	0	.	.	283	285	AAC	362	364	AAC	38;38;38	A;A;C	24;24;24	gyrA.WHO_Z_01155:1:1:N95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_Z_01155	gyrA.WHO_Z_01155	1	1	0	408	gyrA	2751	172	100.0	gyrA.l6.c17.ctg.2	665	15.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	138	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1286	22.4	1	SNP	p	G45D	1	.	.	133	135	GAC	471	473	GAC	52;52;52	G;A;C	34;33;34	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	110	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c17.ctg.1	595	33.7	0	.	n	.	0	A197.	DEL	197	197	A	324	324	A	57	A	35	.	.
parC.WHO_X_00208c	parC.WHO_X_00208c	1	1	27	358	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2865	23.8	1	SNP	p	D86N	0	.	.	256	258	GAC	528	530	GAC	19;19;20	G;A;C	8;7;13	parC.WHO_X_00208c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_X_00208c	parC.WHO_X_00208c	1	1	27	358	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2865	23.8	1	SNP	p	R87W	0	.	.	259	261	CGT	531	533	CGT	20;20;20	C;G;T,C	12;8;11,1	parC.WHO_X_00208c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_X_00208c	parC.WHO_X_00208c	1	1	27	358	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2865	23.8	1	SNP	p	S87R	1	.	.	259	261	CGT	531	533	CGT	20;20;20	C;G;T,C	12;8;11,1	parC.WHO_X_00208c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_X_00208c	parC.WHO_X_00208c	1	1	27	358	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2865	23.8	1	SNP	p	R87I	0	.	.	259	261	CGT	531	533	CGT	20;20;20	C;G;T,C	12;8;11,1	parC.WHO_X_00208c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_X_00208c	parC.WHO_X_00208c	1	1	27	358	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2865	23.8	1	SNP	p	S88P	1	.	.	262	264	CCC	534	536	CCC	20;20;20	C;C;C	11;13;13	parC.WHO_X_00208c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	296	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2706	20.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1491	1493	GGC	19;19;20	G;G;C	13;12;12	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.10.001	penA.10.001	1	1	27	418	penA	1749	1749	100.0	penA.l15.c17.ctg.1	1990	38.7	1	SNP	p	A311V	0	.	.	931	933	GCC	1071	1073	GCC	57;58;58	G;C;C	35;36;34	penA.10.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	418	penA	1749	1749	100.0	penA.l15.c17.ctg.1	1990	38.7	1	SNP	p	I312M	1	.	.	934	936	ATG	1074	1076	ATG	58;58;58	A;T;G	34;33;31	penA.10.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	418	penA	1749	1749	100.0	penA.l15.c17.ctg.1	1990	38.7	1	SNP	p	V316T	1	.	.	946	948	ACC	1086	1088	ACC	60;60;60	A;C;C	36;34;35	penA.10.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	418	penA	1749	1749	100.0	penA.l15.c17.ctg.1	1990	38.7	1	SNP	p	T316P	0	.	.	946	948	ACC	1086	1088	ACC	60;60;60	A;C;C	36;34;35	penA.10.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	418	penA	1749	1749	100.0	penA.l15.c17.ctg.1	1990	38.7	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1587	1589	ACC	33;33;33	A;C,A;C	19;19,1;21	penA.10.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	418	penA	1749	1749	100.0	penA.l15.c17.ctg.1	1990	38.7	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1641	1643	GCG	30;31;31	G;C;G	17;17;17	penA.10.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	418	penA	1749	1749	100.0	penA.l15.c17.ctg.1	1990	38.7	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1641	1643	GCG	30;31;31	G;C;G	17;17;17	penA.10.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	418	penA	1749	1749	100.0	penA.l15.c17.ctg.1	1990	38.7	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1764	1766	GGT	30;30;28	G;G;T	21;22;20	penA.10.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	418	penA	1749	1749	100.0	penA.l15.c17.ctg.1	1990	38.7	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1773	1775	AGC	31;31;31	A;G;C	22;21;21	penA.10.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	418	penA	1749	1749	100.0	penA.l15.c17.ctg.1	1990	38.7	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1791	1793	CCG	30;30;30	C;C;G	20;19;19	penA.10.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	816	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	2780	51.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1492	1494	CCG	32;32;32	C;C;G	18;23;20	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	190	porA	1146	1146	99.83	porA.l6.c4.ctg.1	1994	19.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	598	598	C	17	C	10	.	.
porB1b.WHO_K_02195c	porB1b.WHO_K_02195c	1	1	539	244	porB1b	1047	1047	99.81	porB1b.l15.c4.ctg.1	1493	31.6	0	.	p	.	0	I218M	NONSYN	652	654	ATA	867	869	ATG	52;52;52	A;T;G	35;35;35	.	.
porB1b.WHO_K_02195c	porB1b.WHO_K_02195c	1	1	539	244	porB1b	1047	1047	99.81	porB1b.l15.c4.ctg.1	1493	31.6	0	.	p	.	0	R258C	NONSYN	772	774	CGT	987	989	TGT	46;45;43	T;G;T	29;29;27	.	.
porB1b.WHO_K_02195c	porB1b.WHO_K_02195c	1	1	539	244	porB1b	1047	1047	99.81	porB1b.l15.c4.ctg.1	1493	31.6	1	SNP	p	G120K	1	.	.	358	360	AAG	573	575	AAG	27;27;28	A;A;G	20;19;20	porB1b.WHO_K_02195c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_K_02195c	porB1b.WHO_K_02195c	1	1	539	244	porB1b	1047	1047	99.81	porB1b.l15.c4.ctg.1	1493	31.6	1	SNP	p	D121N	0	.	.	361	363	GAC	576	578	GAC	28;28;28	G,A;A;C	19,1;20;20	porB1b.WHO_K_02195c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_K_02195c	porB1b.WHO_K_02195c	1	1	539	244	porB1b	1047	1047	99.81	porB1b.l15.c4.ctg.1	1493	31.6	1	SNP	p	A121D	1	.	.	361	363	GAC	576	578	GAC	28;28;28	G,A;A;C	19,1;20;20	porB1b.WHO_K_02195c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	972	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	5437	34.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	108	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1190	18.2	1	SNP	p	V57M	1	.	.	169	171	ATG	608	610	ATG	37;36;36	A;T;G	24;24;24	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
